Sarcoma of interdigitating dendritic cells. Case report

Published

2025-01-15

How to Cite

Rodriguez Orozco, J., Mojica Silva, L., Hernandez Lastra, A., Martínez Guerrero, G., Mora Guerrero, D., & Alvarez Romero, J. (2025). Sarcoma of interdigitating dendritic cells. Case report. Oncology Journal (Ecuador), 34(3), 102–108. https://doi.org/10.33821/755

Issue

Section

Case Reports

Authors

DOI:

https://doi.org/10.33821/755

Keywords:

Case report, immunohistochemistry, dendritic cells, PET CT (F18-FDG)

Abstract

Dendritic cells, essential in the immune response by presenting antigens to T and B lymphocytes, can develop extremely rare neoplasms, representing less than 1% of lymph node-originating tumors. We present a case of interdigitating dendritic cell sarcoma that, treated with chemotherapy, showed favorable progression and a good prognosis. Due to the rarity of this disease, it is crucial to consider it in differential diagnoses, as patient survival depends on the stage at which it is detected.

Downloads

Download data is not yet available.

Author Biographies

Jose Rodriguez Orozco, Clínica Bonnadona Prevenir

Departamento de Hematología. Organización Clínica Bonnadona Prevenir, Barranquilla.

Luis Mojica Silva, Clínica Bonnadona Prevenir

Departamento de Medicina Nuclear. Organización Clínica Bonnadona Prevenir, Barranquilla.

Angel Hernandez Lastra, Clínica Bonnadona Prevenir

Departamento de Hematología. Organización Clínica Bonnadona Prevenir, Barranquilla.

Gillian Martínez Guerrero, Clínica Bonnadona Prevenir

Departamento de Epidemiología. Organización Clínica Bonnadona Prevenir, Barranquilla.

Daniela Mora Guerrero, Clínica Bonnadona Prevenir

Semillero de Investigación. Organización Clínica Bonnadona Prevenir, Barranquilla.

Jesus Alvarez Romero, Clínica Bonnadona Prevenir

Semillero de Investigación. Organización Clínica Bonnadona Prevenir, Barranquilla.

References

Campo E, Swerdlow SH, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (Medicine) Revised Edition. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. IARCPRESS; 2017. p. 469.

Santarelli IM, Veltri M, Manzella DJ, Avagnina MA, Pereyra PM, Chavín HC. SARCOMA DISEMINADO DE CÉLULAS DENDRÍTICAS INTERDIGITANTES. CASUÍSTICA MEDICINA. 2017;77:239–41.

Martín-Hernández R, Martínez-Subías JJ, del Rey-Tomás Biosca FJ, Tejero-Cavero M. SARCOMA DE CÉLULAS DENDRÍTICAS INTERDIGITANTES [Internet]. 2019. Available at: www.gaesmedica.com/es-es/

Lakshmanan A, Kurian A, Annapurneswari S. Interdigitating dendritic cell sarcoma involving head and neck region- a report of four cases with review of literature. Human Pathology: Case Reports. 2021 Jun;24.

Pokuri VK, Merzianu M, Gandhi S, Baqai J, Loree TR, Bhat S. Molecular Insights in Patient Care Interdigitating Dendritic Cell Sarcoma NCCN: Continuing Education Accreditation Statement. JNCCN-Journal of the National Comprehensive Cancer Network. 2015 Feb; 13:128–32.

Rosales J, Arrieta E, Ahumada F, Guillermo Restrepo J, Domínguez Durán A, Castaño S, et al. Sarcoma de células dendríticas interdigitantes como segunda neoplasia metacrónica luego de un carcinoma ductal infiltrante de mama: reporte de caso. Revista Colombiana de Hematología y Oncología. 2021;8(1).

Awan U e kalsoom, Siddiqui N, SaadUllah M, Bashir H, Farooqui ZS, Muzaffar N, et al. FDG-PET scan in assessing lymphomas and the application of Deauville Criteria. J Pak Med Assoc. 2013 Jun;63(6):725–30.

Younes A, Hilden P, Coiffier B, Hagenbeek A, Salles G, Wilson W, et al. International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017). Annals of oncology: official journal of the European Society for Medical Oncology. 2017 Jul 1;28(7):1436–47.

Most read articles by the same author(s)